Blood alanine aminotransferase levels >1,000 IU/l - Causes and outcomes

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 15, Issue 3, 2015, Pages 244-247

  Galvin, Zita ^a   McDonough, Anna ^a   Ryan, John ^a   Stewart, Stephen ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Acute hepatitis; Aetiology; Alanine aminotransferase; Prognosis; Transaminases

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; TUBERCULOSTATIC AGENT;

ACUTE HEPATITIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; COMMON BILE DUCT STONE; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FEMALE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS E; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LIVER ISCHEMIA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OUTPATIENT CARE; PROGNOSIS; PROGNOSTIC ASSESSMENT; RETROSPECTIVE STUDY; TOXIC HEPATITIS; VARICELLA ZOSTER VIRUS; VIRUS HEPATITIS; BLOOD; ENZYMOLOGY; LIVER DISEASES;

ALANINE TRANSAMINASE; FEMALE; HUMANS; LIVER DISEASES; MALE; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84931836119     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.15-3-244     Document Type: Article

References (17)

1. Zimmerman HJ, West M. Serum enzyme levels in the diagnosis of hepatic disease. Am J Gastroenterol 1963;40:387-404.
2. Ellis G, Goldberg DM, Spooner RJ, Ward AM. Serum enzyme tests in diseases of the liver and biliary tree. Am J Clin Pathol 1978;70:248-58.
3. Xu HM1, Chen Y, Xu J, Zhou Q. Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase. World J Gastroenterol 2012;18:5972-8.
4. Hickman PE, Potter JM. Mortality associated with ischaemic hepatitis. Aust N Z J Med 1990;20:32-4.
5. Lee WM, Seremba E. Etiologies of acute liver failure. Curr Opin Crit Care 2008;14:198-201.
6. Manns MP, Czaja AJ, Gorham et al. Diagnosis and management of acute hepatitis. Hepatology 2010;51:2193-213.
7. Dufour DR1, Lott JA, Nolte FS et al. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 2000;46:2050-68.
8. Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ 2005;172:367-79.
9. Fry SW, Seeff LB. Hepatotoxicity of analgesics and anti-inflammatory agents. Gastroenterol Clin North Am 1995;24:875-905.
10. Rozen P, Korn RJ, Zimmerman HJ. Computer analysis of liver function tests and their interrelationships in 347 cases of viral hepatitis. Isr J Med Sci 1970;6:67-79.
11. Nathwani RA, Kumar SR, Reynolds TB, Kaplowitz N. Marked elevation in serum transaminases: an atypical presentation of choledocholithiasis. Am J Gastroenterol 2005;100:295-8.
12. Agahi A, McNair A. Choledocholithiasis presenting with very high transaminase level. BMJ Case Rep 2012;pii:bcr2012007268.
13. Kessler WR, Cummings OW, Eckert G et al. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol 2004;2:625-31.
14. Yeoman AD, Westbrook RH, Zen Y et al. Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome. J Hepatol 2014;61:876-82.
15. Riveiro-Barciela M, Rodríguez-Frías F, Buti M. Hepatitis E virus: new faces of an old infection. Ann Hepatol 2013;12:861-70.
16. Haffar S, Bazerbachi F, Lake JR. Making the case for the development of a vaccination against hepatitis E virus. Liver Int 2015;35:311-6.
17. Tajiri K, Shimizu Y.Practical guidelines for diagnosis and early management of drug-induced liver injury. World J Gastroenterol 2008;14:6774-85.